The global market for Biosensors is estimated at US$30.4 Billion in 2023 and is projected to reach US$49.3 Billion by 2030, growing at a CAGR of 7.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the biosensor market is driven by several factors. Firstly, the rising prevalence of chronic diseases and the need for early diagnosis and monitoring are boosting the demand for biosensors in the healthcare sector. Secondly, advancements in nanotechnology and materials science are enhancing the performance and functionality of biosensors. Thirdly, the growing focus on personalized medicine and the increasing adoption of point-of-care testing are driving the development of portable and user-friendly biosensors.
Additionally, the expansion of the food and environmental safety sectors is supporting the use of biosensors for detecting contaminants and ensuring compliance with safety standards. Lastly, government initiatives and funding for biosensor research and development are further propelling market growth, ensuring the continued evolution and application of these vital analytical devices.
The growth in the biosensor market is driven by several factors. Firstly, the rising prevalence of chronic diseases and the need for early diagnosis and monitoring are boosting the demand for biosensors in the healthcare sector. Secondly, advancements in nanotechnology and materials science are enhancing the performance and functionality of biosensors. Thirdly, the growing focus on personalized medicine and the increasing adoption of point-of-care testing are driving the development of portable and user-friendly biosensors.
Additionally, the expansion of the food and environmental safety sectors is supporting the use of biosensors for detecting contaminants and ensuring compliance with safety standards. Lastly, government initiatives and funding for biosensor research and development are further propelling market growth, ensuring the continued evolution and application of these vital analytical devices.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Non-wearable Biosensors segment, which is expected to reach US$25.9 Billion by 2030 with a CAGR of a 6.6%. The Wearable Biosensors segment is also set to grow at 7.8% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $11.9 Billion in 2023, and China, forecasted to grow at an impressive 8.7% CAGR to reach $5.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Biosensors Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Biosensors Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Biosensors Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Abbott Laboratories, Bio-Rad Laboratories, Inc., Cytiva, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 119 Featured):
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Cytiva
- Dexcom, Inc.
- Masimo Corporation
- Medtronic Plc
- Nova Biomedical
- Siemens Medical Solutions USA, Inc.
- Thermo Fisher Scientific Inc.
- WaveForm Technologies, Inc.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAJAPANFRANCEGERMANYITALYUNITED KINGDOMREST OF EUROPEREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CHINA
EUROPE
ASIA-PACIFIC
Companies Mentioned
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Cytiva
- Dexcom, Inc.
- Masimo Corporation
- Medtronic Plc
- Nova Biomedical
- Siemens Medical Solutions USA, Inc.
- Thermo Fisher Scientific Inc.
- WaveForm Technologies, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 504 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 30.4 Billion |
| Forecasted Market Value ( USD | $ 49.3 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
